Clinical research and pharmaceutical testing CRO for Latin America
Synvia operates a full-service contract research organization (CRO) across Brazil, conducting clinical trials (Phase I–IV), bioequivalence studies, and bioanalytical testing. The stack reveals a regulated-industry foundation—SAP ERP, Power BI, R, and analytical instruments (LC-MS/MS, HPLC)—paired with in-house digital products (Synvia eCRF for electronic case reports). Hiring patterns show research-heavy scaling (20 roles) alongside operational and finance functions, reflecting the resource intensity of managing 1,600+ concurrent studies and maintaining regulatory compliance (ANVISA, CAP, EMA, FDA standards).
Synvia is a privately held clinical research organization headquartered in Paulínia, São Paulo, serving the pharmaceutical and biotech industries across Latin America and expanding internationally. The company operates multiple specialized labs: a central bioanalytical lab, a 30+ LC-MS/MS instrument analytical park (largest in Latin America), and clinical trial sites. Over 20 years, Synvia has processed bioequivalence data for more than 50% of generic medications commercialized in Brazil, alongside Phase I–IV trial management and regulatory submissions. Staff includes over 800 personnel, including dozens of postgraduate scientists. The company combines contract research services with digital solutions (eCRF software, Life Sciences software suite) designed to meet international quality standards at competitive cost.
SAP Business One (ERP), Power BI (analytics), R (statistical analysis), GCP (cloud), plus specialized lab instruments: LC-MS/MS and HPLC. Office suite (Word, Excel, Outlook, PowerPoint) for documentation and reporting.
Paulínia, São Paulo, Brazil. Currently hiring exclusively in Brazil; 501–1,000 employees across research, clinical, analytical, regulatory, and software teams.
Other companies in the same industry, closest in size